Bellevue Group AG Q3 2017 Filing
Filed November 13, 2017
Portfolio Value
$956.1B
Holdings
131
Report Date
Q3 2017
Filing Type
13F-HR
All Holdings (131 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | CAHCARDINAL HEALTH INC | 20,000 | $1.3B | 0.14% | |
| 102 | —BIOVERATIV INC | 22,750 | $1.3B | 0.14% | |
| 103 | DVAXDYNAVAX TECHNOLOGIES CORP | 59,500 | $1.3B | 0.13% | |
| 104 | —INTERSECT ENT INC | 41,000 | $1.3B | 0.13% | |
| 105 | EX9EXELIXIS INC | 52,000 | $1.3B | 0.13% | |
| 106 | —HMS HLDGS CORP | 53,500 | $1.1B | 0.11% | |
| 107 | PFEPFIZER INC | 29,200 | $1.0B | 0.11% | |
| 108 | PODDINSULET CORP | 18,000 | $991.0M | 0.10% | |
| 109 | GKOSGLAUKOS CORP | 30,000 | $990.0M | 0.10% | |
| 110 | —ENDO INTL PLC | 115,000 | $985.0M | 0.10% | |
| 111 | NVROEURNEVRO CORP | 10,700 | $972.0M | 0.10% | |
| 112 | INOINOVIO PHARMACEUTICALS INC | 144,000 | $913.0M | 0.10% | |
| 113 | —COTIVITI HLDGS INC | 21,708 | $781.0M | 0.08% | |
| 114 | —MEDICINES CO | 19,500 | $722.0M | 0.08% | |
| 115 | CVSCVS HEALTH CORP | 8,800 | $716.0M | 0.07% | |
| 116 | VAREURVARIAN MED SYS INC | 7,000 | $700.0M | 0.07% | |
| 117 | ITCIEURINTRA CELLULAR THERAPIES INC | 40,000 | $631.0M | 0.07% | |
| 118 | —GW PHARMACEUTICALS PLC | 6,000 | $609.0M | 0.06% | |
| 119 | —ENVISION HEALTHCARE CORP | 13,026 | $586.0M | 0.06% | |
| 120 | —QUOTIENT LTD | 110,000 | $542.0M | 0.06% | |
| 121 | —CEMPRA INC | 165,000 | $536.0M | 0.06% | |
| 122 | —ADAMAS PHARMACEUTICALS INC | 24,000 | $508.0M | 0.05% | |
| 123 | TBPHTHERAVANCE BIOPHARMA INC | 14,428 | $494.0M | 0.05% | |
| 124 | ICPTUSDINTERCEPT PHARMACEUTICALS IN | 8,500 | $493.0M | 0.05% | |
| 125 | MYGNMYRIAD GENETICS INC | 13,000 | $470.0M | 0.05% | |
| 126 | —CELLDEX THERAPEUTICS INC NEW | 160,000 | $458.0M | 0.05% | |
| 127 | —OBALON THERAPEUTICS INC | 48,000 | $457.0M | 0.05% | |
| 128 | —AAC HLDGS INC | 45,000 | $447.0M | 0.05% | |
| 129 | —ALDER BIOPHARMACEUTICALS INC | 33,000 | $404.0M | 0.04% | |
| 130 | ESPRESPERION THERAPEUTICS INC NEW | 8,000 | $401.0M | 0.04% | |
| 131 | SGRYSURGERY PARTNERS INC | 31,000 | $321.0M | 0.03% |
PreviousPage 2 of 2